Explore more publications!

Health Monitor Liechtenstein: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Monitor Liechtenstein.

Press releases published on November 13, 2025

Kura Oncology and Kyowa Kirin Announce FDA Approval of KOMZIFTI™ (ziftomenib), the First and Only Once-Daily Targeted Therapy for Adults with Relapsed or Refractory NPM1-Mutated Acute Myeloid Leukemia
Legend Senior Living® Expands Presence to New Jersey, Welcoming Azalea of Cinnaminson
Inventiva announces trading resumption of its ordinary shares on Euronext Paris
Inventiva annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris
Zone School of Healing Celebrates Eight-Year Milestone as One of the Fastest-Growing Chiropractic & Healing Schools Worldwide
U.S. Oral Surgery Management Secures New Partner Practices in Three States
Global Molecular Diagnostics Market Set to Reach USD 30.74 Billion by 2030 | MarketsandMarkets™
Inventiva announces pricing of upsized public offering of approximately $150M of American Depositary Shares
Inventiva annonce les modalités définitives ainsi que l'extension de l'offre au public d'American Depositary Shares d'approximativement 150 millions de dollars
NeOnc Technologies Completes Enrollment in Pivotal NEO100 Phase2a Trial for IDH-1 mutant Recurrent High‑Grade Glioma and Expects Interim Data Readout in SixMonths (Q22026)
Parents Say Teens are Checked Out and Need Mental Health Support, According to New Report
HealthEquity to Enhance Member Experience with Agentic AI
New technology empowers Canadian hospitals to securely advance transformative research
Une nouvelle technologie permet aux hôpitaux canadiens de faire progresser la recherche transformatrice en toute sécurité
LiveWorld Reports Third Quarter 2025 Financial Results
AtaiBeckley to Participate in the Jefferies Global Healthcare Conference in London
Inspira Completes Clinical Study for HYLA™ Blood Sensor - Ahead of Regulatory Submission
Clearmind Medicine Receives Final Approval to Expand its FDA Regulated Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center
Theriva™ Biologics presenta los aspectos operativos más destacados y los resultados financieros del tercer trimestre de 2025
Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions